Clinical trial
Efficacy Trial on Oral Miltefosine in Comparison With Glucantime in the…
NCT00351520 · Tehran University of Medical Sciences, Other · Completed
Key facts
| NCT number | NCT00351520 |
|---|---|
| Title | Efficacy Trial on Oral Miltefosine in Comparison With Glucantime in the Treatment of ACL Caused by L. Tropica |
| Official title | Phase 3, Clinical Trials of Drug Against Cutaneous Leishmaniasis |
| Lead sponsor | Tehran University of Medical Sciences, Other |
| Collaborators | World Health Organization |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cutaneous Leishmaniasis |
| Intervention type | Drug |
| Interventions | Miltefose |
| Enrollment | 148 |
| Start date | May 1, 2006 |
| Completion | Jun 1, 2007 |
| First posted | Jul 13, 2006 |
| Last update posted | Sep 20, 2011 |
| Countries | Iran |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: